Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia

International Journal of Antimicrobial Agents

Volumn 30, Issue 4, 2007, Pages 289-296

  Morgan, M S ^a  

^a ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CA MRSA; Community associated methicillin resistant Staphylococcus aureus; Necrotising pneumonia; Panton Valentine leukocidin

Indexed keywords

ACTIVATED PROTEIN C; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ABSCESS; BACTERIAL PNEUMONIA; CLINICAL FEATURE; EXTRACORPOREAL OXYGENATION; HUMAN; INCIDENCE; LEUKOPENIA; LYMPHOCYTOPENIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PANTON VALENTINE LEUKOCIDIN ASSOCIATED STAPHYLOCOCCAL PNEUMONIA; PRIORITY JOURNAL; RADIODIAGNOSIS; SHORT SURVEY; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; EXOTOXINS; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCIDINS; PNEUMONIA, STAPHYLOCOCCAL; PROTEIN C; STAPHYLOCOCCUS AUREUS;

EID: 34548440173     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.04.019     Document Type: Short Survey

References (88)

1. Wiita R.M., Cartwright R.R., and Davis J.G. Staphylococcal pneumonia in adults. A review of 102 cases. Am J Roentgenol Radium Ther Nucl Med 86 (1961) 1083-1091
2. Ede S., Davis G.M., and Holmes F.H. Staphylococci pneumonia. JAMA 170 (1959) 638-643
3. Lina G., Piedmont Y., Godail-Gaot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29 (1999) 1128-1132
4. Gillet Y., Issartel B., Vanhems P., et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 59 (2002) 753-759
5. Panton P.N., and Valentine F.C.O. Staphylococcal toxin. Lancet i (1932) 506-508
6. Crawford S.E., and Daum R.S. Epidemic community-associated methicillin-resistant Staphylococcus aureus: modern times for an ancient pathogen. Pediatr Infect Dis J 24 (2005) 459-460
7. Holmes A., Ganner M., McGuane S., Pitt T.L., Cookson B.D., and Kearns A.M. Staphylococcus aureus isolates carrying Panton-Valentine leukocidin genes in England and Wales: frequency, characterisation and association with clinical disease. J Clin Microbiol 43 (2005) 2384-2390
8. Zetola N., Frances J.S., Neuremberger E.L., and Bishai W.R. Community acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet 5 (2005) 275-286
9. Klein A.J., Petrovic Z., Treacher D., and Edgeworth J. Severe community-acquired pneumonia caused by Panton-Valentine leukocidin positive Staphylococcus aureus: first reported case in the United Kingdom. Intensive Care Med 29 (2003) 1399
10. Agwu A., Brady K.M., Ross T., Carroll K.C., and Halsey N.A. Cholera-like diarrhea and shock associated with community-acquired methicillin-resistant Staphylococcus aureus (USA400 clone) pneumonia. Pediatr Infect Dis J 26 (2007) 271-273
11. Adem P.V., Montgomery C.P., Husain A.N., et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 353 (2005) 1245-1251
12. Banthia S., Meka V.G., Pillai S.K., et al. A fatal case of necrotizing pneumonia caused by community-associated methicillin-resistant Staphylococcus aureus. Infect Dis Clin Pract 13 (2005) 132-138
13. Boussaud V., Parrot A., Mayaud C., et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med 292 (2003) 1840-1843
14. Chalumeau M., Bidet P., Leina G., et al. Transmission of Panton-Valentine leukocidin-producing Staphylococcus aureus to a physician during resuscitation of a child. Clin Infect Dis 41 (2005) e29-e30
15. Conley J., Gilbert M., Zahang K., et al. Rapidly progressive fatal necrotising pneumonitis (FNP) secondary to Panton-Valentine leukocidin (PVL)+ SCCmec type IVa community-acquired methicillin-resistant S. aureus (CAMRSA)-a harbinger of the future?. Can J Infect Dis Med Microbiol 16 (2005) 109-110
16. Dufour P., Gillet Y., Bes M., et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 35 (2002) 819-824
17. Francis J.S., Doherty M.C., Lopatin U., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40 (2005) 100-107
18. Garnier F., Tristan A., Francois B., et al. Pneumonia and a new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis 12 (2006) 498-500
19. Gilbert M., MacDonald J., Gregson D., et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 175 (2006) 149-154
20. Gonzalez B.E., Hulten K.G., Dishop M.K., et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis 41 (2005) 583-590
21. Hageman J.C., Uyeki T.M., Francis J.S., et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 12 (2006) 894-899
22. Hsu L.Y., Coh T.-H., Amantham D., Kurup A., Chan K.P.W., and Tan B.-H. Panton-Valentine leukocidin-positive Staphylococcus aureus, Singapore. Emerg Infect Dis 10 (2004) 1509-1510
23. Hyvernat H., Pulcini C., Carles D., et al. Fatal Staphylococcus aureus haemorrhagic pneumonia producing Panton-Valentine leucocidin. Scand J Infect Dis 39 (2007) 183-185
24. Janvier J., Elsayed S., Gregson D., et al. Necrotising pneumonia secondary to community-associated methicillin-resistant S aureus (CA-MRSA) USA300 strain without evidence of antecedent viral respiratory tract infection. Can J Infect Dis Med Microbiol 17 (2006) 310-315
25. Joguet G., Perez J.M., Herrmann C., and Strobel M. Lethal necrotising pneumonia by Panton-Valentine leukocidin-producing Staphylococcus aureus. Medec Mal Infectieuses 5 (2003) 272-273
26. Jones T.F., Crech B., Erwin P., Baird S.G., Woron I.S., and Schaffner W. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 42 (2006) e76-e77
27. Kravitz G.R., Dries D.J., Peterson M.L., and Schlievert P.M. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 40 (2005) 941-947
28. Laporte-Turpin E., Marcoux M.-O., Claudet I., et al. Necrotizing pneumonia and arthritis due to Staphylococcus aureus producing Panton and Valentine leukocidin in a 10-year-old boy. Arch Pediatr 13 449-452 (2006) [in French]
29. Linde J., Wagenlehner F., Strommenger B., et al. Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in south-eastern Germany. Eur J Clin Microbiol Infect Dis 24 (2005) 419-422
30. Lopez-Aguilar C., Perez-Roth E., Mendez-Alvarez S., et al. Association between the presence of the Panton-Valentine leukocidin-encoding gene and a lower rate of survival among hospitalized pulmonary patients with staphylococcal disease. J Clin Microbiol 45 (2007) 274-276
31. Ma X.X., Galiana A., Pedeira W., et al. Community-acquired methicillin-resistant Staphylococcus aureus, Uruguay. Emerg Infect Dis 11 (2005) 973-976
32. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota 1997-1999. JAMA 1999; 282:1123-1125.
33. Mongkolrattanothal K., Boyle S., Kahana M.D., and Daum R.S. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 37 (2003) 1050-1058
34. Obed A., Schnitzbauer A.A., Bein T., Lehn N., Linde H.-J., and Schlitt H.J. Fatal pneumonia caused by Panton-Valentine leucocidine-positive methicillin-resistant Staphylococcus aureus (PVL-MRSA) transmitted from a healthy donor in living-donor liver transplantation. Transplantation 81 (2006) 121-124
35. Osterlund A., Kahlmeter B., Bieber L., Runehagen A., and Breider J.-M. Intrafamilial spread of highly virulent Staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin. Scand J Infect Dis 34 (2002) 763-787
36. Peleg A.Y., Munckhof W.J., Kleinschmidt S.L., Stephens A.J., and Huygens F. Life-threatening community-acquired meticillin-resistant Staphylococcus aureus infection in Australia. Eur J Infect Dis 24 (2005) 384-387
37. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325-329.
38. Ek T., Andersson O., Kasemo A.U., Wede M., and Nilsson P.A. PVL positive Staph aureus as the cause of necrotizing pneumonia. Description of three severe cases in earlier healthy young persons. Lakartidningen 7 (2007) 509-513 [in Swedish]
39. Tseng M.-H., Wei B.-H., Lin W.J., et al. Fatal sepsis and necrotizing pneumonia in a child due to community-acquired methicillin-resistant Staphylococcus aureus: case report and literature review. Scand J Infect Dis 37 (2005) 504-507
40. van der Flier M., Van Dijk N.B., Fluit A.C., Fleer A., Wolfs T.F.W., and van Gestel J.P.J. Fatal pneumonia in an adolescent due to community-acquired methicillin-resistant Staphylococcus aureus positive for Panton-Valentine-leukocidin. Ned Tijdschr Geneeskd 147 (2003) 1076-1079 [in Dutch]
41. Al-Tawfiq J.A., and Aldaabil R.A. Community-acquired MRSA bacteremic necrotizing pneumonia in a patient with scrotal ulceration. J Infect 51 (2005) e241-e243
42. Enayet I., Johnson L.B., Riederer K., Pawlak J., and Saravolatz L.D. Community-associated methicillin-resistant Staphylococcus aureus causes chronic pneumonia. Clin Infect Dis 42 (2006) e57-e60
43. Fortunov R.M., Hulten K.G., Hammerman W.A., Mason E.O., and Kaplan S.L. Community-acquired Staphylococcus aureus infection in term and near-term previously healthy neonates. Pediatrics 118 (2006) 874-881
44. Hampson F.G., Hancock S.W., and Primhak R.A. Disseminated sepsis due to a Panton-Valentine leukocidin producing strain of community acquired meticillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy. Arch Dis Child 91 (2006) 201-203
45. Hsu L.Y., Coh T.H., Amantham D., Kurup A., Chan K.P.W., and Tan B.-H. Community associated methicillin-resistant Staphylococcus aureus, Singapore. Emerg Infect Dis 11 (2005) 341-342
46. Jeyaratnam D., Reid C., Kearns A., and Klein J. Community-associated MRSA: an alert to paediatricians. Arch Dis Child 91 (2006) 511-512
47. Laifer G., Frei R., Adler H., and Fluckiger U. Necrotising pneumonia complicating a nasal furuncle. Lancet 9522 (2006) 1628
48. Le Thomas I., Mariani-Kurkdjian P., Collignon A., et al. Breast milk transmission of Panton-Valentine leukocidin-producing strain causing infantile pneumonia. J Clin Microbiol 39 (2001) 728-729
49. Martin B.T., Palasanthiran P., Gosbell I.B., Barbagiannakos T., Best E.J., and Henry R.L. Severe childhood pneumonitis caused by the Queensland strain of community-acquired methicillin-resistant Staphylococcus aureus. Med J Aust 182 (2005) 249
50. Micek S.T., Dunne M., and Kollef M.H. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 128 (2005) 2732-2738
51. Mijklaevics E., Haeggman S., Sanchez B., Martinsons A., Olsson-Liljequist B., and Dumpis U. Report on the first PVL-positive community acquired MRSA strain in Latvia. Euro Surveill 9 (2004) 29-30
52. Monaco M., Antonucci R., Palange P., Venditti M., and Pantosti A. Methicillin-resistant Staphylococcus aureus necrotizing pneumonia. Emerg Infect Dis 10 (2005) 1647-1648
53. Miyashita T., Shimamoto Y., Nishiya H., et al. Destructive pulmonary embolism in a patient with community-acquired staphylococcal bacteremia. J Infect Chemother 8 (2002) 99-102
54. Nimmo G.R., and Playford E.G. Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust 178 (2003) 245-246
55. Petros S., Eggers B., Heuer M., et al. Severe community acquired pneumonia due to Staphylococcus aureus. Intensive Care Med 28 (1998) 189
56. Salliot C., Zeller V., Puechal X., et al. Panton-Valentine leukocidin-producing Staphylococcus aureus infections: report of 4 French cases. Scand J Infect Dis 38 (2006) 192-234
57. Torrell E., Molin D., Tabno E., Ehrenborg C., and Ryden C. Community-acquired pneumonia and bacteraemia in a healthy young woman caused by methicillin-resistant Staphylococcus aureus (MRSA) carrying the genes encoding Panton-Valentine leukocidin (PVL). Scand J infect Dis 7 (2005) 902-904
58. Tronci M., Parisi G., Pantosti A., Monaco M., and Valentini P. A CA MRSA strain with decreased vancomycin susceptibility as a cause of serious invasive infection in an immunocompetent adolescent. 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)-25th International Congress of Chemotherapy (ICC); 31 March-3 April. Munich, Germany (2007) Poster 1599
59. Diep B.A., Chang R.F., Phan T.H., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367 (2006) 731-739
60. Ramdani-Bougessa N., Bes M., Meugnier H., et al. Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital. Antimicrob Agents Chemother 50 (2006) 1083-1085
61. de Bentzmann S., Tristan A., Etienne J., Brousse N., Vandenesch F., and Lina G. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type IV and laminin. J Infect Dis 190 (2004) 1506-1515
62. Seeger W., Birkemeyer R.G., Emert L., Suttorp N., Bhakdi S., and Duncker H.-R. Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest 63 (1990) 341-349
63. Voyich J.M., Otto M., Mahema B., et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J Infect Dis 1 (2006) 761-770
64. Labandeira-Rey M., Couzon F., Boisset S., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotising pneumonia. Science 315 (2007) 1130-1133
65. Etienne J. Panton-Valentine leukocidin: a mark of severity for Staphylococcus aureus infection?. Clin infect Dis 41 (2006) 591-593
66. Musher D.M., and Franco M. Staphylococcal pneumonia. A new perspective. Chest 79 (1981) 172-173
67. Chickering H.T., and Park J.H. Staphylococcus aureus pneumonia. JAMA 72 (1919) 617-626
68. Stevens D.L., Ma Y., McIndoo E., Wallace R.J., and Bryant A. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195 (2007) 202-211
69. Scheetz M.H., Wunderink R.G., Postelnick M.J., and Noskin G.A. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia. Pharmacotherapy 26 (2006) 539-550
70. Graber C.J., Wong M.K., Carleton H.A., Perdreau-Remington F., Haller B.L., and Chambers H.F. Intermediate vancomycin susceptibility in community associated MRSA clone. Emerg Infect Dis 13 (2007) 491-493
71. Francis J.S., Carroll K., Nuermberger E., and Bartlett J.G. Authors' reply. Clin Infect Dis 40 (2005) 1378-1379
72. Wargo K.A., and Eiland E.H. Appropriate antimicrobial therapy for community-acquired methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40 (2005) 1376-1377
73. Shelbourne A.S.A., Musher D.M., Hulten K., Lu H.Y., Bhaila I., and Hamill R.J. In vitro killing of community associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob Agents Chemother 48 (2004) 4016-4019
74. Dumitrescu O., Boisset S., Bes M., et al. Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin. Antimicrob Agents Chemother 51 (2007) 1515-1519
75. Bernardo K., Pakulat N., Fleer S., et al. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 48 (2004) 546-559
76. Van Langeveldes P., van Dissel C.J.C., Renz J., and Groeneveld P.H.P. Combination of flucloxacillin and gentamicin inhibits toxic shock syndrome toxin 1 production by Staphylococcus aureus in both logarithmic and stationary phases of growth. Antimicrob Agents Chemother 41 (1997) 1682-1685
77. Ohlsen K., Ziebuhr W., Koller P., Hell W., Wichelhaus T.A., and Hacker J. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 42 (1998) 2817-2823
78. Chavez-Bueno A., Bozdogan B., Katz K., et al. Inducible clindamycin resistance and molecule epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother 49 (2005) 2283-2288
79. Silverman J.A., Mortin L.I., Vanpraagh A.D., and Alder J. Inhibition of daptomycin by pulmonary surfactant: in vitro modelling and impact. J Infect Dis 191 (2005) 2149-2152
80. Von Freyberg J., Scherpe J., Horstkotte M.A., and Knobloch J.K. Activity of moxifloxacin against community-acquired MRSA and other quinolone-susceptible MRSA isolates. 16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 1-4 April. Nice, France (2006) Abstract o305
81. McAleese F., Murphy E., Babinchak K., et al. Use of ribotyping to retrospectively identify methicillin-resistant Staphylococcus aureus isolates from phase 3 clinical trials for tigecycline that are genotypically related to community isolates. Antimicrob Agents Chemother 49 (2005) 4521-4529
82. Moise P.A., and Schentag H.J. Vancomycin treatment failure in Staphylococcus aureus pneumonia. Int J Antimicrob Agents 16 (2000) 3231-3234
83. Gaudauchon V., Cozon G., and Vandenesch F. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis 189 (2004) 346-353
84. Darenberg J., Soderquist B., Normark B.N., and Norrby-Teglund A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications and therapy of toxic shock syndrome. Clin Infect Dis 38 (2004) 826-842
85. Werdan K. Intravenous immunoglobulin for prophylaxis and therapy of sepsis. Curr Opin Crit Care 7 (2001) 354-361
86. Coyle E.A. Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infection. Pharmacotherapy 5 (2003) 638-642
87. Bell N.J., Dodd J.W., Patel B.D., and Morgan M.S. Necrotising pneumonia due to Panton-Valentine leukocidin producing Staphylococcus aureus treated with intravenous immunoglobulin [poster and oral presentation]. Thorax 61 Suppl. ii (2006) 100
88. Petersen M.L., and Schlievert P.M. Glycerol monolaurate inhibits the effect of Gram positive select agents on eukaryotic cells. Biochemistry 45 (2006) 2387-2397